ClinicalTrials.govpublic full text
A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19
covid-19, mrx-4dp0004, coronavirus, live biotherapeutic product, sars-cov-2, immunomodulatory, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830409
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.